1.53 -0.05 (-3.16%)

77.60% Fall from 52W High

72,939 XNAS Volume

XNAS 09 May, 2025 5:30 PM (EDT)

Board Meeting
The board meeting for BioXcel Therapeutics Inc is scheduled for today, for the purpose of BioXcel Therapeutics Inc First Quarter Earnings Results for 2025 See details

BioXcel Therapeutics Inc - BTAI - stock price prediction, stock price target, analyst ratings from 4 analysts

BioXcel Therapeutics Inc has a share price target of US$ 36, revenue growth forecast of 47.6%, and profit growth estimate of -13.7% for FY25, based on top 4 analyst calls.